by Benzinga | January 12, 2026 8:19 pm | US Markets
WASHINGTON, Jan. 12, 2026 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (the “Company”) announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company’s fourth quarter 2025 performance in a...
by Benzinga | January 12, 2026 8:19 pm | US Markets
Bank of America (NYSE:BAC) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 14. Analysts expect the bank to report fourth-quarter earnings of 96 cents per share. That’s up from 82 cents per share in the year-ago period. The...
by Benzinga | January 12, 2026 8:16 pm | US Markets
Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) — DETAILS OF EARNING CALL January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial in: To join:...
by Benzinga | January 12, 2026 7:14 pm | Crypto News
Coinbase (NASDAQ:COIN) has warned U.S. lawmakers it could withdraw support for a major crypto market-structure bill if new provisions restrict its ability to offer rewards on stablecoin holdings. What Happened: The bill is headed for Senate committee markup this week,...
by Benzinga | January 12, 2026 7:14 pm | US Markets
– Strong Sephience™ (sepiapterin) launch continues with unaudited Q4 global revenue of $92.5M – – Unaudited 2025 total product and royalty revenue of approximately $823M, exceeding guidance – – 2026 product revenue guidance of $700 – 800M, representing 19 – 36%...
by Benzinga | January 12, 2026 7:13 pm | US Markets
Full year revenue growth of approximately 94% driven by strong performance in molecular profiling services IRVING, Texas, Jan. 12, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ:CAI), a leading, patient-centric, next-generation AI TechBio company and...
by Benzinga | January 12, 2026 7:11 pm | US Markets
SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) — Outset Medical, Inc. (NASDAQ:OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal...
by Benzinga | January 12, 2026 7:10 pm | US Markets
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues of $4.4 million In the dose escalation phase of the Phase 1b study of R289 in patients with lower-risk MDS, R289 continues...
by Benzinga | January 12, 2026 7:10 pm | US Markets
Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth quarter Full year unaudited revenue from continuing operations of $96.2 million exceeded the high end of the previously raised guidance range for...
by Benzinga | January 12, 2026 6:38 pm | Crypto News
Monero (CRYPTO: XMR) surged to a new all-time high of $579 Monday, rising over 20% in 24 hours as veteran trader Peter Brandt identified XMR forming a pattern similar to silver’s classic inverse head-and-shoulders that preceded a 150% rally. The Silver Pattern Behind...
by Benzinga | January 12, 2026 6:36 pm | Crypto News
Bitcoin is trading around $90,000 as broader crypto sentiment remains neutral despite macro tailwinds; liquidations stand at $211.88 million over the past 24 hours. Bitcoin ETFs saw $250 million in net outflows on Friday, while Ethereum ETFs reported $93.8 million...
by Benzinga | January 12, 2026 6:35 pm | US Markets
SAN DIEGO, Jan. 12, 2026 /PRNewswire/ — Petco (NASDAQ:WOOF) today announced the launch of a debt refinancing transaction to extend maturities and reaffirmed its guidance for the fourth quarter and full fiscal year 2025 ending January 31, 2026....
by Benzinga | January 12, 2026 6:35 pm | US Markets
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA – January 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the “Company” or...
by Benzinga | January 12, 2026 6:34 pm | US Markets
Citigroup Inc. (NYSE:C) will release earnings results for the fourth quarter, before the opening bell on Wednesday, Jan. 14, 2026. Analysts expect the New York-based bank to report quarterly earnings at $1.72 per share, up from $1.35 per share in the year-ago period....
by Benzinga | January 12, 2026 6:33 pm | US Markets
SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today...
by Benzinga | January 12, 2026 6:31 pm | US Markets
Home Bancshares, Inc. (NYSE:HOMB) will release earnings results for the fourth quarter, after the closing bell on Wednesday, Jan. 14. Analysts expect the Conway, Arkansas-based company to report quarterly earnings at 60 cents per share, up from 50 cents per share in...
by Benzinga | January 12, 2026 6:30 pm | US Markets
Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range of 73% to 75% DrugSorb®-ATR De Novo Pre-Submission Meeting scheduled with the FDA this month, with...
by Benzinga | January 12, 2026 6:30 pm | US Markets
– Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 – – Top-Line Data from the Phase 3 XPORT-EC-042 Trial in Endometrial Cancer on Track for Mid-2026 – – Preliminary Unaudited Full Year 2025 Total Revenue and U.S. XPOVIO® (selinexor)...
by Benzinga | January 12, 2026 6:29 pm | US Markets
The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO BOSTON and ROLLE, Switzerland, Jan. 12, 2026 /PRNewswire/ — SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision...
by Benzinga | January 12, 2026 6:28 pm | US Markets
MOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal...
